Advertisement

Topics

Companies Related to "Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women" [Most Relevant Company Matches] RSS

10:00 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women" found in our extensive corporate database of over 50,000 company records.

Showing "Breeze3 Study Gabapentin Extended Release Treatment Vasomotor Symptoms" Companies 1–25 of 4,200+

Relevant

Highland Therapeutics Inc.

Highland Therapeutics Inc. is a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., is leveraging its proprietary technology, DELEXIS™, to optimize the delivery of previously approved drug products. The Company’s lead product candidates, HLD-200 and HLD-100, are novel formulati...


Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsid...


Procter & Gamble Pharmaceuticals

Three billion times a day, P&G brands touch the lives of people around the world. P&G has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R) (risedronate sodium) tablets, Asacol(R) (mesalamine) delayed-release tablets, Asacol(R) HD (mesalamine) delayed-release tablets, Enablex(R) (darifenacin) extended release tablets, Prilosec OTC(R), Align(R), Metamucil(...

Depomed, Inc.

Depomed, Inc. is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development, two approved products on the market and other product candidates in its early stage pipeline. Product candidate DM-1796 has completed Phase 3 clinical development and has been licensed to Abbott Produ...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

Bionovo

Bionovo is a publicly traded pharmaceutical company focused on discovering and developing drugs for women's health and cancer. Bionovo is a leader in systems-biology integration with candidates designed to address specific targets associated with the regulation of pathological conditions. The company is working simultaneously on two distinct discovery approaches, one focusing on pro-apoptotic ag...

Antares Pharma, Inc.

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company's subcutaneous and intramuscular injection technology platforms include VIBEXTM disposable pressure-assisted auto injectors, ValeoTM/VisionTM reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, ...

Antares Pharma, Inc. and Population Council

Antares Pharma focuses on self-injection delivery technologies and topical gel-based pharmaceutical products. The Company’s subcutaneous injection technology platforms include VibexTM disposable pressure-assisted auto injectors, ValeoTM/Vision® reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, Antares Pha...

Collegium Pharmaceutical Inc.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent protected DETERx® formulation platform for the treatment of chronic pain. The DETERx oral drug delivery technology provides extended release delivery, unique tamper resistant properties, and flexible dose adminis...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

Cypress Bioscience

We are committed to being the innovator and leader in providing products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome, or FMS, and other central nervous system disorders. Specifically, our strategy involves acquiring or in-licensing central nervous system, or CNS, active compounds and developing them for novel and typically underserved indications....

Nanopoint Inc.

Nanopoint, Inc. ( www.nanopointimaging.com ) is a privately-held life sciences company that is advancing the study & treatment of diseases with its extended time-lapse live cell imaging solutions. Nanopoint's patented cellTRAY, automated microfluidics delivery system, on-stage incubator and imaging software provides solutions to a broad spectrum of applications including drug discovery, assisted r...

BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol...

Caron Treatment Centers

Caron Treatment Centers is a nationally recognized non-profit provider of alcohol and drug addiction treatment. With more than 50 years in the field, Caron is one of the oldest and largest facilities offering primary, relapse and extended residential treatment for young adults, adults and adolescents, as well as families affected by the disease of addiction. Caron's gender separate and gender spec...

DiObex, Inc.

DiObex is a biotechnology company engaged in the development of novel products for metabolic disease. DIO-901 (very low dose glucagon) is in development in two convenient delivery forms for the prevention of nocturnal hypoglycemia induced by insulin intensification. Insulin-induced hypoglycemia, which occurs most frequently at night, is a major limitation in the aggressive management of hype...

Rochester Medical

It's all about quality of life for Rochester Medical. The company focuses on urinary incontinence and urinary retention treatment products, including male external catheters and urethral inserts for women. The firm's RELEASE-NF catheter is designed to prevent urinary tract infections. Most of the company's products are made of silicone rather than latex to reduce the risk of allergic reactions. Ro...

Urigen Holdings Inc

Urigen is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for urological disorders. Urigen has five products in development for urology indications that are either in or positioned to enter Phase 2 clinical trials. The pipeline includes U101, for which a Phase 2b study in on-going for the treatment of Chronic Pelvic Pain (CPP); U102, ta...

National MS Society

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to loss of vision and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us ...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

RESprotect GmbH

RESprotect GmbH from Dresden develops drugs that prevent induction of chemoresistance of tumor cells and enhance their chemosensitivity. This concept is worldwide without concurrence. The first drug RP101 significantly extended survival time of pancreas cancer patients in a clinical pilot study.

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

International Dairy Queen Inc.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180319005808/en/


More From BioPortfolio on "Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks